About The Position

We are sharing a specialised consulting opportunity for experienced Pharmacovigilance and Drug Safety professionals with strong expertise in DSURs, PSURs/PBRERs, aggregate safety analysis, signal management, benefit-risk assessment, MedDRA coding, and regulatory safety documentation to contribute to an advanced AI training and pharmacovigilance evaluation project. Selected professionals will review complex drug-safety materials, assess aggregate and case-level information, evaluate signal and benefit-risk conclusions, and provide structured feedback grounded in current pharmacovigilance standards. No prior experience in AI is required.

Requirements

  • 5+ years of pharmacovigilance or drug-safety experience
  • Experience at a sponsor, CRO, or as an independent consultant
  • Demonstrated experience authoring or reviewing DSURs and/or PSURs/PBRERs end to end
  • Strong working knowledge of ICH E2F, ICH E2C(R2), and relevant GVP guidance
  • Experience with signal management and benefit-risk assessment
  • Hands-on MedDRA coding experience
  • Strong knowledge of seriousness, causality, and expectedness assessment
  • Demonstrated ability to reconcile aggregate and case-level safety data
  • Strong regulatory-documentation, analytical, and written communication skills
  • No prior AI-training or model-evaluation experience is required

Nice To Haves

  • Advanced degree in life sciences, pharmacy, nursing, medicine, or a related discipline is highly valuable
  • Development-stage and post-marketing safety experience is advantageous
  • QPPV, deputy QPPV, or safety-committee experience is beneficial

Responsibilities

  • Review DSURs, PSURs/PBRERs, and related safety documentation for accuracy, completeness, and regulatory relevance
  • Assess interval and cumulative safety information and associated case-level data
  • Apply ICH E2F, ICH E2C(R2), and relevant GVP requirements
  • Review report structure, appendices, and data presentation
  • Identify issues affecting the defensibility of safety conclusions
  • Evaluate emerging and established safety signals and supporting evidence
  • Assess benefit-risk conclusions across development-stage and post-marketing settings
  • Apply MedDRA coding principles and review seriousness, causality, and expectedness determinations
  • Reconcile aggregate conclusions with underlying case information
  • Identify unsupported assumptions, classification issues, or changes affecting the overall safety profile
  • Reconcile case counts, figures, and safety data across reports and source materials
  • Identify discrepancies between aggregate and case-level information
  • Review AI-generated pharmacovigilance content for technical and regulatory accuracy
  • Provide clear written rationales explaining evaluation decisions and identified deficiencies
  • Support consistent quality standards across pharmacovigilance evaluation tasks

Benefits

  • Independent contractor engagement
  • Fully remote
  • Compensation: $70–$80/hour
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service